DiaMedica Therapeutics Inc. (DMAC) stock

DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 6/30

$9.66−0.01 (-0.10%)

Close on Nov 11, 2026Market cap $520.92MP/E –Yield –

DiaMedica Therapeutics ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

DiaMedica Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?